| Literature DB >> 32758418 |
Sho Kitamoto1, Hiroko Nagao-Kitamoto1, Yizu Jiao2, Merritt G Gillilland1, Atsushi Hayashi3, Jin Imai1, Kohei Sugihara1, Mao Miyoshi1, Jennifer C Brazil4, Peter Kuffa1, Brett D Hill5, Syed M Rizvi5, Fei Wen5, Shrinivas Bishu1, Naohiro Inohara4, Kathryn A Eaton6, Asma Nusrat4, Yu L Lei7, William V Giannobile7, Nobuhiko Kamada8.
Abstract
The precise mechanism by which oral infection contributes to the pathogenesis of extra-oral diseases remains unclear. Here, we report that periodontal inflammation exacerbates gut inflammation in vivo. Periodontitis leads to expansion of oral pathobionts, including Klebsiella and Enterobacter species, in the oral cavity. Amassed oral pathobionts are ingested and translocate to the gut, where they activate the inflammasome in colonic mononuclear phagocytes, triggering inflammation. In parallel, periodontitis results in generation of oral pathobiont-reactive Th17 cells in the oral cavity. Oral pathobiont-reactive Th17 cells are imprinted with gut tropism and migrate to the inflamed gut. When in the gut, Th17 cells of oral origin can be activated by translocated oral pathobionts and cause development of colitis, but they are not activated by gut-resident microbes. Thus, oral inflammation, such as periodontitis, exacerbates gut inflammation by supplying the gut with both colitogenic pathobionts and pathogenic T cells.Entities:
Keywords: Klebsiella; TH17; colitis; dysbiosis; inflammasome; inflammatory bowel disease; microbiota; oral bacteria; pathobiont; periodontitis
Mesh:
Substances:
Year: 2020 PMID: 32758418 PMCID: PMC7414097 DOI: 10.1016/j.cell.2020.05.048
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582